Arch Therapeutics, Inc. (OTCMKTS:ARTH) Short Interest Update

Arch Therapeutics, Inc. (OTCMKTS:ARTH) was the recipient of a significant drop in short interest in November. As of November 15th, there was short interest totalling 13,200 shares, a drop of 9.6% from the October 31st total of 14,600 shares. Based on an average trading volume of 13,900 shares, the days-to-cover ratio is currently 0.9 days.

Arch Therapeutics Stock Performance

Shares of Arch Therapeutics stock remained flat at $0.21 during midday trading on Friday. 22 shares of the stock were exchanged, compared to its average volume of 5,850. Arch Therapeutics has a fifty-two week low of $0.17 and a fifty-two week high of $18.00. The firm has a 50 day moving average of $0.32 and a 200 day moving average of $0.67.

About Arch Therapeutics

Arch Therapeutics, Inc, together with its subsidiaries, operates as a biotechnology company in the United States. It develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease.